Department of Endocrinology, University of Groningen, University Medical Center Groningen, P.O. Box 30001, 9700 RB, Groningen, The Netherlands.
Ancora Health B.V., Herestraat 106, 9711 LM, Groningen, The Netherlands.
Sci Rep. 2023 Feb 20;13(1):1351. doi: 10.1038/s41598-023-27637-w.
The growing public interest in genetic risk scores for various health conditions can be harnessed to inspire preventive health action. However, current commercially available genetic risk scores can be deceiving as they do not consider other, easily attainable risk factors, such as sex, BMI, age, smoking habits, parental disease status and physical activity. Recent scientific literature shows that adding these factors can improve PGS based predictions significantly. However, implementation of existing PGS based models that also consider these factors requires reference data based on a specific genotyping chip, which is not always available. In this paper, we offer a method naïve to the genotyping chip used. We train these models using the UK Biobank data and test these externally in the Lifelines cohort. We show improved performance at identifying the 10% most at-risk individuals for type 2 diabetes (T2D) and coronary artery disease (CAD) by including common risk factors. Incidence in the highest risk group increases from 3.0- and 4.0-fold to 5.8 for T2D, when comparing the genetics-based model, common risk factor-based model and combined model, respectively. Similarly, we observe an increase from 2.4- and 3.0-fold to 4.7-fold risk for CAD. As such, we conclude that it is paramount that these additional variables are considered when reporting risk, unlike current practice with current available genetic tests.
公众对各种健康状况的遗传风险评分越来越感兴趣,可以利用这一点来激发预防性健康行动。然而,目前市场上可获得的遗传风险评分可能具有欺骗性,因为它们没有考虑到其他容易获得的风险因素,如性别、BMI、年龄、吸烟习惯、父母疾病状况和身体活动。最近的科学文献表明,增加这些因素可以显著提高基于 PGS 的预测。然而,实施现有的基于 PGS 的模型,同时考虑这些因素,需要基于特定基因分型芯片的参考数据,而这并不总是可用的。在本文中,我们提供了一种不依赖于基因分型芯片的方法。我们使用英国生物库的数据进行模型训练,并在 Lifelines 队列中进行外部测试。我们通过纳入常见风险因素,证明了在识别 2 型糖尿病 (T2D) 和冠状动脉疾病 (CAD) 中风险最高的 10%人群方面,性能有所提高。在最高风险组中,与基于遗传学的模型、基于常见风险因素的模型和综合模型相比,T2D 的发病率从 3.0 倍和 4.0 倍分别增加到 5.8 倍。同样,我们观察到 CAD 的风险从 2.4 倍和 3.0 倍分别增加到 4.7 倍。因此,我们得出结论,与当前可用的遗传测试的当前实践不同,在报告风险时,必须考虑这些额外的变量。